GKOS Glaukos Corp

$130.76 +2.53%

Healthcare · Surgical & Medical Instruments & Apparatus

Glaukos Corp (GKOS) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $7.7 billion. Shares last traded at $130.76, 11.7% below their 52-week high. Over the past year the stock is up 30.9%. Net profit margin is -37.0%, below the peer median of -7.6%. Revenue grew 32.3% year over year.

Market Cap

$7.7B

Shares Out

58.7M

EPS (TTM)

$-2.27

P/E Ratio

—

P/S Ratio

15.13

P/B Ratio

11.45

Dividend / Share

—

Dividend Yield

—

52-Week High

$148.15

52-Week Low

$73.60

Volume

35,371

Avg Vol (3m)

76,841.413

Performance

+5.26%

-6.50%

+28.10%

+14.93%

YTD

+18.01%

+30.89%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

56.78

SMA (50)

$125.95

SMA (200)

$107.80

Price vs SMA50

+3.82%

Price vs SMA200

+21.30%

ATR (14)

$6.39

Financials

Revenue

$507M

Net Income

$-188M

Gross Margin

55.7%

Operating Margin

-39.3%

Net Margin

-37.0%

Return on Equity

-28.0%

Return on Assets

-21.0%

Current Ratio

5.43

Debt / Equity

0.00

Revenue Growth (YoY)

+32.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.34	2026-04-30
FY 2025	$-3.28	2026-02-23
Q3 2025	$-0.95	2025-10-31
Q2 2025	$-0.66	2025-08-04
Q1 2026	$-0.32	2026-04-30
FY 2025	$-2.77	2026-02-23

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

GKOS vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

15.13 / 2.52 med

+501% premium

Net margin vs peers

-37.0% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.